Kossan Rubber Industries Bhd

KLSE:KOSSAN Stock Report

Market Cap: RM 4.8b

Kossan Rubber Industries Bhd Valuation

Is KOSSAN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of KOSSAN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: KOSSAN (MYR1.9) is trading above our estimate of fair value (MYR1.82)

Significantly Below Fair Value: KOSSAN is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for KOSSAN?

Other financial metrics that can be useful for relative valuation.

KOSSAN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.7x
Enterprise Value/EBITDA12.5x
PEG Ratio1.7x

Price to Earnings Ratio vs Peers

How does KOSSAN's PE Ratio compare to its peers?

The above table shows the PE ratio for KOSSAN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average50.7x
HARTA Hartalega Holdings Berhad
100.4x44.4%RM 9.7b
AP4 Riverstone Holdings
15.6x7.8%S$1.3b
STGT Sri Trang Gloves (Thailand)
63.2x35.9%฿33.5b
688289 Sansure Biotech
23.5x17.2%CN¥10.1b
KOSSAN Kossan Rubber Industries Bhd
46.7x28.0%RM 4.8b

Price-To-Earnings vs Peers: KOSSAN is good value based on its Price-To-Earnings Ratio (46.7x) compared to the peer average (50.7x).

Price to Earnings Ratio vs Industry

How does KOSSAN's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.1%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a21.1%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: KOSSAN is expensive based on its Price-To-Earnings Ratio (46.7x) compared to the Asian Medical Equipment industry average (22.7x).

Price to Earnings Ratio vs Fair Ratio

What is KOSSAN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

KOSSAN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio46.7x
Fair PE Ratio43.5x

Price-To-Earnings vs Fair Ratio: KOSSAN is expensive based on its Price-To-Earnings Ratio (46.7x) compared to the estimated Fair Price-To-Earnings Ratio (43.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst KOSSAN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 1.90
RM 2.22
+16.6%
20.1%RM 3.10RM 1.56n/a15
Sep ’25RM 1.82
RM 2.22
+21.7%
20.1%RM 3.10RM 1.56n/a15
Aug ’25RM 2.09
RM 2.37
+13.2%
19.7%RM 3.23RM 1.48n/a16
Jul ’25RM 2.40
RM 2.37
-1.1%
19.8%RM 3.23RM 1.48n/a16
Jun ’25RM 2.22
RM 2.32
+4.4%
22.4%RM 3.23RM 1.48n/a16
May ’25RM 2.20
RM 1.87
-15.1%
19.2%RM 2.40RM 1.33n/a16
Apr ’25RM 1.95
RM 1.86
-4.8%
18.5%RM 2.35RM 1.33n/a16
Mar ’25RM 1.89
RM 1.86
-1.8%
18.5%RM 2.35RM 1.33n/a16
Feb ’25RM 2.05
RM 1.64
-20.2%
22.7%RM 2.30RM 1.23n/a16
Jan ’25RM 1.85
RM 1.54
-16.6%
23.0%RM 2.30RM 1.00n/a17
Dec ’24RM 1.69
RM 1.41
-16.6%
13.3%RM 1.75RM 1.00n/a16
Nov ’24RM 1.35
RM 1.20
-10.8%
17.3%RM 1.60RM 0.88n/a16
Oct ’24RM 1.32
RM 1.20
-8.8%
17.3%RM 1.60RM 0.88n/a16
Sep ’24RM 1.32
RM 1.20
-9.2%
17.0%RM 1.60RM 0.88RM 1.8217
Aug ’24RM 1.41
RM 1.20
-15.0%
17.0%RM 1.60RM 0.88RM 2.0917
Jul ’24RM 1.29
RM 1.12
-13.2%
17.8%RM 1.42RM 0.83RM 2.4017
Jun ’24RM 1.46
RM 1.12
-23.3%
17.8%RM 1.42RM 0.83RM 2.2217
May ’24RM 1.25
RM 1.12
-10.6%
17.7%RM 1.42RM 0.83RM 2.2017
Apr ’24RM 1.31
RM 1.12
-14.3%
23.9%RM 1.90RM 0.78RM 1.9518
Mar ’24RM 1.07
RM 1.09
+1.5%
23.0%RM 1.90RM 0.78RM 1.8918
Feb ’24RM 1.05
RM 1.15
+9.3%
22.8%RM 1.90RM 0.75RM 2.0518
Jan ’24RM 1.10
RM 1.18
+7.3%
20.8%RM 1.90RM 0.85RM 1.8518
Dec ’23RM 1.09
RM 1.18
+8.3%
20.8%RM 1.90RM 0.85RM 1.6918
Nov ’23RM 1.21
RM 1.29
+6.5%
18.2%RM 1.90RM 0.85RM 1.3518
Oct ’23RM 1.08
RM 1.31
+20.9%
18.3%RM 1.90RM 0.85RM 1.3218
Sep ’23RM 1.02
RM 1.38
+35.5%
18.3%RM 2.05RM 1.03RM 1.3218

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y